Rakovina Therapeutics Inc. Announces Closing of $1.5 Million Convertible Debenture Financing
29 mai 2023 20h57 HE
|
Rakovina Therapeutics Inc
VANCOUVER, British Columbia, May 29, 2023 (GLOBE NEWSWIRE) -- Rakovina Therapeutics Inc. (“Rakovina” or the “Company”) (TSX-V: RKV) is pleased to announce that it has closed its previously announced...
Rakovina Therapeutics Inc. Announces 2022 Financial Results and Convertible Debenture Financing
01 mai 2023 22h44 HE
|
Rakovina Therapeutics Inc
VANCOUVER, British Columbia, May 01, 2023 (GLOBE NEWSWIRE) -- Rakovina Therapeutics Inc. (TSX-V: RKV, the “Company”) a biopharmaceutical company committed to advancing new cancer therapies based on...
Rakovina Therapeutics Announces Presentation of New kt-3000 Series Data at AACR Annual Meeting
20 avr. 2023 12h47 HE
|
Rakovina Therapeutics Inc
VANCOUVER, British Columbia, April 20, 2023 (GLOBE NEWSWIRE) -- Rakovina Therapeutics Inc. (the “Company”) (TSXV:RKV) today announced the presentation of new data describing the progress of the...
Rakovina Therapeutics to Present at the Emerging Growth Conference on April 19, 2023
17 avr. 2023 18h18 HE
|
Rakovina Therapeutics Inc
VANCOUVER, British Columbia, April 17, 2023 (GLOBE NEWSWIRE) -- Rakovina Therapeutics Inc. (TSX-V: RKV) (“Rakovina” or the “Company”) is pleased to announce that it has been invited to present at...
Rakovina Therapeutics Inc. Announces Enhanced Liquidity and Investor Awareness Programs
30 mars 2023 09h00 HE
|
Rakovina Therapeutics Inc
VANCOUVER, British Columbia, March 30, 2023 (GLOBE NEWSWIRE) -- Rakovina Therapeutics Inc. (the “Company”) (TSXV:RKV) today announced the engagement of Red Cloud Securities (“Red Cloud”) and...
Rakovina Therapeutics Receives Funding to Accelerate Development of Novel Cancer Therapies
22 mars 2023 09h00 HE
|
Rakovina Therapeutics Inc
VANCOUVER, British Columbia, March 22, 2023 (GLOBE NEWSWIRE) -- Rakovina Therapeutics Inc. (TSXV: RKV) (“the Company”), is pleased to announce that it is receiving advisory services and up to...
Rakovina Therapeutics Inc. Announces Plan to Apply to Extend Warrant Expiry Dates
10 mars 2023 20h36 HE
|
Rakovina Therapeutics Inc
VANCOUVER, British Columbia, March 10, 2023 (GLOBE NEWSWIRE) -- Rakovina Therapeutics Inc. (the “Company”) (TSXV:RKV) announces that it may apply to the TSX Venture Exchange (the “TSXV”) to extend...
Rakovina Therapeutics Announces Presentation at the 6th Annual DDR-inhibitors Summit
26 janv. 2023 23h45 HE
|
Rakovina Therapeutics Inc
VANCOUVER, British Columbia, Jan. 26, 2023 (GLOBE NEWSWIRE) -- Rakovina Therapeutics Inc. (TSX-V: RKV) (“the Company”), is pleased to announce a scientific presentation at the 6th Annual DDR...
Rakovina Therapeutics to Present at the Emerging Growth Conference on November 30, 2022
23 nov. 2022 09h00 HE
|
Rakovina Therapeutics Inc
VANCOUVER, British Columbia, Nov. 23, 2022 (GLOBE NEWSWIRE) -- Rakovina Therapeutics Inc. (TSX-V: RKV) (“Rakovina” or the “Company”), a biopharmaceutical company committed to advancing new cancer...
Rakovina Therapeutics Inc. Announces Q3 2022 Financial Results and Provides Corporate Update
17 nov. 2022 09h00 HE
|
Rakovina Therapeutics Inc
VANCOUVER, British Columbia, Nov. 17, 2022 (GLOBE NEWSWIRE) -- Rakovina Therapeutics Inc. (TSX-V: RKV, the “Company”) a biopharmaceutical company committed to advancing new cancer therapies based on...